Zealand Pharma A/S ADR (ZEAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZEAL | IMTX | EYPT | ||
| Company | Zealand Pharma A/S ADR | Immatics NV | Eyepoint Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 18.03 | 10.01 | 16.26 | ||
| High | 18.07 | 10.04 | 16.26 | ||
| Low | 17.47 | 9.67 | 15.51 | ||
| Last | 17.59 | 9.78 | 16.16 | ||
| Change | +0.21 | -0.37 | -0.31 | ||
| % Change | +1.21% | -3.65% | -1.88% | ||
| Volume | 2,100 | 685,100 | 749,600 | ||
| 20-Day Average Volume | 2,250 | 374,375 | 918,650 | ||
| Previous Close | 17.38 | 10.15 | 16.47 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 18.09 | 10.52 | 19.90 | ||
| 20-Day Raw Stochastic | 27.14% | 7.01% | 7.99% | ||
| 20-Day Relative Strength | 50.34% | 35.47% | 32.56% | ||
| Weighted Alpha | -38.80 | -2.77 | -30.20 | ||
| Today's Opinion | 48% Buy | 40% Sell | 8% Sell | ||
| Previous Opinion | 32% Buy | 40% Sell | 8% Sell | ||
| Last Month's Opinion | 24% Buy | 40% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.11% since 09/21/22 | -4.68% since 04/18/24 | -7.66% since 04/18/24 | ||
| Low | 16.54 on 09/27/22 | 9.67 on 04/25/24 | 15.51 on 04/25/24 | ||
| High | 18.07 on 09/29/22 | 10.61 on 04/24/24 | 18.68 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | +2.45% since 08/29/22 | -13.53% since 03/25/24 | -25.50% since 03/25/24 | ||
| Low | 16.51 on 09/19/22 | 9.67 on 04/25/24 | 15.51 on 04/25/24 | ||
| High | 20.03 on 09/09/22 | 11.69 on 03/27/24 | 23.65 on 04/12/24 | ||
| 3-Month | |||||
| %Chg | +32.96% since 06/29/22 | -16.62% since 01/25/24 | -35.10% since 01/25/24 | ||
| Low | 12.82 on 07/01/22 | 9.67 on 04/25/24 | 15.51 on 04/25/24 | ||
| High | 20.49 on 08/25/22 | 13.16 on 03/01/24 | 30.99 on 02/08/24 | ||
| 6-Month | |||||
| %Chg | +20.23% since 03/29/22 | +20.00% since 10/25/23 | +154.89% since 10/25/23 | ||
| Low | 9.93 on 05/16/22 | 7.15 on 10/31/23 | 5.67 on 10/30/23 | ||
| High | 20.49 on 08/25/22 | 13.16 on 03/01/24 | 30.99 on 02/08/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 818,603 | 827,955 | 805,269 | ||
| Shares Outstanding, K | 46,538 | 84,658 | 49,831 | ||
| Annual Sales | 46,550,000 | 58,440,000 | 46,020,000 | ||
| Annual Net Income | -161,990,000 | -104,980,000 | -70,800,000 | ||
| Last Quarter Sales | 4,060,000 | 17,100,000 | 14,030,000 | ||
| Last Quarter Net Income | -69,960,000 | -28,110,000 | -14,100,000 | ||
| 60-Month Beta | 1.45 | 0.67 | 1.64 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.40 on 08/11/22 | -0.32 on 03/21/24 | -0.33 on 03/07/24 | ||
| Latest Earnings Date | 11/10/22 | 05/21/24 | 05/01/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||